Telix Pharmaceuticals Limited

TLXNASDAQHealthcare● Active

$9.29

$-0.01(-0.11%)

Market Cap$3.1B

P/E Ratio—

52W High$18.49

52W Low$6.28

Avg Volume200K

Open$9.40

Beta0.59

Net Income Financials Revenue

Telix Pharmaceuticals Limited (TLX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

TLX · net income · updated Jun 8, 2026

Core profitability metrics

TLX · net income · margin · TTM · CAGR

Net income was −$10.7M for FY2025 (fiscal year ending 2025-12-31), down 121.4% year-over-year. Net profit margin was -0.9%. Based on available data, Telix Pharmaceuticals Limited has been profitable since at least 2023.

FY2025 Net Income−$10.7M▼ -121.4% YoY

Trailing 12M (TTM)$39.2Mtrailing 4 quarters sum

Net Profit Margin-0.9%−$10.7M ÷ $1.21B

YoY Change-121.4%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2023

▸ FMP /income-statement · Annual · TLX net income history · TLX profit margin

Annual net income data

TLX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$10.7M▼ 121.4%-0.9%$1.21B

FY2024$49.9M▲ +858.0%6.4%$783.2M

FY2023★ First Profit$5.2M▲ +105.0%1.0%$502.5M

FY2022Loss−$104.1M▼ 29.3%-65.0%$160.1M

FY2021Loss−$80.5M▼ 79.4%-1059.9%$7.6M

Net income vs peers (Healthcare)

TLX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Telix Pharmaceuticals LimitedYOU

TLX

−$10.7M-121.4%-0.9%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Telix Pharmaceuticals Limited (TLX) reported net income of −$10.7M for FY2025 (fiscal year ending 2025-12-31), down 121.4% year-over-year. The net profit margin was -0.9% — meaning the company kept $-0.01 of every dollar of revenue as profit.

Based on available data, Telix Pharmaceuticals Limited has been profitable since at least 2023. Net income reached a peak of $49.9M in FY2024. Data available for 13 fiscal years.

Telix Pharmaceuticals Limited's net profit margin was -0.9% for FY2025, based on the latest annual results.

Investors sometimes search for "Telix Pharmaceuticals Limited net worth" — the company's market capitalization is a separate figure from TLX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

TLX net income · 5 questions

Telix Pharmaceuticals Limited is not currently profitable on an annual basis. The company reported a net loss of $10.7M for FY2025.

is TLX profitabledoes TLX make a profitTLX profitabilityTLX profitable company

▸ Source: FMP /income-statement · GAAP · Telix Pharmaceuticals Limited · Telix Pharmaceuticals Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026